Matched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletion. Post category:Hematologic Cancers Reading time:1 min read This study developed an allogeneic matched donor CD19 CAR product (CAR-DLI) for adult patients with B-cell acute lymphob... Continue ReadingMatched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletion.